Oct. 31, 2013Topics
Trial And Error - Despite a 150-year history and an aggregate R&D expenditure of $150 billion per year, innovation in the modern pharmaceutical industry is essentially still based on trial and error. Only 1 out of 5,000-10,000 ...
Oct. 11, 2013Topics
Development On Trial - The number of biopharmaceutical projects in clinical trials and products is increasing, playing an important role in new treatments.
Jul. 08, 2013News & Opinions
Saltigo has signed an agreement with Tokyo-based Daiichi Sankyo for the provision of contract manufacturing services; this comes ahead of Daiichi Sankyo's plans to commercialize one of its novel drug pipeline projects. Financial details ...
May. 14, 2013News & Opinions
Aesica, the global contract manufacturing organisation (CMO), announces a partnership with the University of Nottingham for the commercial development of alternative methods in amide bond synthesis.
Mar. 28, 2013News & Opinions
Vetter, a contract development and manufacturing organization (CDMO), announced today that its new center for visual inspection and logistics passed its first GMP inspection by the U.S. Food and Drug Administration (FDA). The inspection ...
Feb. 05, 2013News & Opinions
Aesica, an international contract manufacturing organization (CMO), has appointed Jarrett Palmer as Operations Director of its formulated products business unit.
Jan. 30, 2013Topics
Codexis, headquartered in Redwood City, California, USA is a developer of enzymes and processes for the production of pharmaceuticals, biofuels and bio-based chemicals. Following the termination of a funding agreement for research in the ...
Dec. 18, 2012News & Opinions
Aesica, the global contract manufacturing organisation (CMO), announces its second major innovation board partnership following the recent annual Genesis conference, a famed hotbed of future innovation.
Nov. 04, 2012News & Opinions
Applikon Biotechnology, a global supplier of bioreactor control systems to the biopharma market, today announced the signing of a bilateral supply agreement with Thermo Fisher Scientific.
Oct. 25, 2012News & Opinions
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that it has signed a biologics contract manufacturing agreement with Paranta Biosciences of Melbourne , Australia.
The latest information directly via newsletter.